Asset Planning Corporation
- SEC CIK
- 0000007773
- Latest filing
- Nov 6, 2025
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Asset Planning Corporation, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q3 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −280−100.0% | Sold out | Holders |
| Q3 2024 | 280 | $294.3K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 280 | $294.3K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 280 | $269.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2023 | 280 | $245.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 280 | $230.4K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 280 | $201.2K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2023 | 280 | $230.1K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 280 | $202.0K | 0.2% | +280 | New | Holders |